A Day Up For CymaBay Therapeutics, Inc.

Tue 12 May 20 at 05:30 PM
A Day Up For CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc. (CBAY:NASDAQ) soared at $4.18, a gain of 127.2%. On Mon 11 May 20, CBAY:NASDAQ hit a New 2-Week Intraday High of $1.88. The stock appeared on our News Catalysts scanner on Mon 04 May 20 at 06:57 PM in the 'EARNINGS' category. From Mon 27 Apr 20, the stock recorded 60.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About CymaBay Therapeutics, Inc. (CBAY:NASDAQ)

CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.